Accès ouvert déclaré 2025 article

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Zhuxuan Fu, Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna DeFazio, Penelope M. Webb, Martin Köbel, Nicola S. Meagher, Renhua Na, Antonis C. Antoniou, Alison H. Brand, Catherine J. Kennedy, Nikilyn Nevins, Paul D.P. Pharoah, Yurii B. Shvetsov, Stacey J. Winham, Jennifer Alsop, Matthias W. Beckmann, Adelyn Bolithon, Jessica Boros, David D.L. Bowtell, James D. Brenton, Michael E. Carney, Anita Chudecka-Głaz, Linda Cook, Cezary Cybulski, Peter A. Fasching, Sián Fereday, Renée T. Fortner, María Jesús García García, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, Arndt Hartmann, Brenda Y. Hernandez, Estrid Høgdall, David G. Huntsman, Allan Jensen, Mercedes Jimenez-Linan, Janine M. Joseph, Beth Y. Karlan, Ewa Kaznowska, Susanne K. Kjær, Tomasz Kluz, Jennifer M. Koziak, Jenny Lester, Teri A. Longacre, Maria Lycke, Valerie McGuire, Kirsten B. Moysich, Rachel A. Murphy, Sandra Oršulić, Susan J. Ramus, Cristina Rodríguez‐Antona, Joseph H. Rothstein, Spinder Samra, Weiva Sieh, Helen Steed, Karin Sundfeldt, Aline Talhouk, Jan Uciński, Chen Wang, Nicolas Wentzensen, Alice S. Whittemore, Lynne R. Wilkens, Thomas J. Songer, Maria M. Brooks, Lu Tang, Francesmary Modugno

3Citations signalées — pas une note de qualité

57Institutions déclarées

11Pays d’affiliation déclarés

Résumé indisponible : les résultats de l’étude ne doivent pas être déduits depuis son seul titre.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Date Crossref: 01/07/2025
Éditeur: Elsevier BV
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Saint Luke's Health System University of Pittsburgh South Carolina Department of Health and Environmental Control University of South Carolina Cancer Institute of New South Wales Cancer Council NSW Queensland Health The University of Queensland QIMR Berghofer Medical Research Institute Foothills Medical Centre University of Cambridge Cancer Research UK Westmead Hospital Westmead Institute for Medical Research Cedars-Sinai Medical Center Cancer Center of Hawaii Mayo Clinic in Arizona Mayo Clinic in Florida Cancer Research UK Cambridge Center Comprehensive Cancer Center Erlangen UNSW Sydney Peter MacCallum Cancer Centre University of Hawaiʻi at Mānoa Pomeranian Medical University Colorado School of Public Health International Hereditary Cancer Center German Cancer Research Center Heidelberg University Cancer Registry of Norway Instituto de Investigaciones Biomédicas Sols-Morreale Universidad Autónoma de Madrid Herlev Hospital BC Cancer Agency University of British Columbia Danish Cancer Society Addenbrooke's Hospital Roswell Park Comprehensive Cancer Center University of California, Los Angeles Rzeszów University of Technology University of Rzeszów University of Copenhagen Copenhagen University Hospital University of Calgary Stanford Medicine Stanford University Sahlgrenska University Hospital Centre for Biomedical Network Research on Rare Diseases Icahn School of Medicine at Mount Sinai The University of Texas MD Anderson Cancer Center Alberta Health Services Alberta Health University of Gothenburg Vancouver General Hospital National Cancer Institute Department of Health Magee-Womens Research Institute UPMC Hillman Cancer Center

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Ovarian cancer diagnosis and treatmentEstrogen and related hormone effectsBRCA gene mutations in cancer

Consulter la publication primaire DOI